These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6409711)

  • 1. Preparation of factor VIII-free plasma by immunoaffinity chromatography on insolubilized antibodies against factor VIII-related antigen.
    Tran TH; Duckert F
    Haemostasis; 1983; 13(2):73-7. PubMed ID: 6409711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigations on the relationship of factor VIII related antigen, factor VIII procoagulant activity and Von Willebrand factor activity using insolubilized rabbit antiserum.
    Bouma BN; de Graaf S; Hordijk-Hos JM; van Mourik JA; Sixma JJ
    Thromb Res; 1975 Nov; 7(5):695-707. PubMed ID: 1082181
    [No Abstract]   [Full Text] [Related]  

  • 3. Heterogeneity of human procoagulant factor VIII (VIIIC) antibodies in their reaction with factor VIII related antigen (VIIIRAG).
    Furlong RA; Peake IR
    Thromb Res; 1984 Jun; 34(5):379-87. PubMed ID: 6204399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on human factor VIII and its antibodies using radiolabelling and affinity chromatography.
    Kavanagh ML; Wood CN; Davidson JF
    Thromb Haemost; 1981 Jun; 45(3):267-71. PubMed ID: 6792739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of factor VIII deficient plasma by immunodepletion using three monoclonal antibodies.
    Takase T; Rotblat F; Goodall AH; Kernoff PB; Middleton S; Chand S; Denson KW; Austen DE; Tuddenham EG
    Br J Haematol; 1987 Aug; 66(4):497-502. PubMed ID: 3117089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired von Willebrand's disease. Evidence for a quantitative and qualitative factor VIII disorder.
    Joist JH; Cowan JF; Zimmerman TS
    N Engl J Med; 1978 May; 298(18):988-91. PubMed ID: 306064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the factor VIII complex in diabetic ketoacidosis: evidence of endothelial cell damage?
    Greaves M; Pickering C; Knight G; Boulton AJ; Ball J; Ward JD; Preston FE
    Diabetologia; 1987 Mar; 30(3):160-5. PubMed ID: 3108060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of factor-VIII-depleted plasma with antibodies and its use for the assay of factor VIII.
    Rothschild C; Amiral J; Adam M; Meyer D
    Haemostasis; 1990; 20(6):321-8. PubMed ID: 2129163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoradiometric assay of procoagulant factor VIII antigen (VIIICAG).
    Muller HP; van Tilburg NH; Bertina RM; Terwiel JP; Veltkamp JJ
    Clin Chim Acta; 1980 Oct; 107(1-2):11-9. PubMed ID: 6775848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoaffinity purification of factor VIII complex.
    Hornsey VS; Griffin BD; Pepper DS; Micklem LR; Prowse CV
    Thromb Haemost; 1987 Feb; 57(1):102-5. PubMed ID: 3109055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered serum factor VIII-related antigen (VIII : AGN)/von Willebrand factor (VIII : vWf) in haemophiliacs with inhibitors to factor VIII procoagulant activity (VIII : C).
    Ballard JO; Sanders JC; Eyster ME
    Thromb Haemost; 1981 Feb; 45(1):68-72. PubMed ID: 6166064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of the inhibitor of factor VIII:C in patients with hemophilia A. A study of the cooperative group of hemophilia.
    Ambriz-Fernández R; Reyna-Fregoso MP; Pizzuto-Chávez J; Rodríguez-Moyado H; Farfán-Canto JM; Trueba-Christy E; Collazo-Jaloma J
    Arch Invest Med (Mex); 1985; 16(3):225-35. PubMed ID: 3938639
    [No Abstract]   [Full Text] [Related]  

  • 14. The mechanism of factor VIII inactivation by human antibodies. II. The effect of factor VIII R: antigen on the rate of interaction.
    Lazarchick J
    Ann Clin Lab Sci; 1985; 15(1):76-82. PubMed ID: 3918497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Von Willebrand's disease: studies of platelet functions, factor VIII procoagulant activity (F VIII C) and factor VIII-related antigen (F VIII RAg) in three families.
    Mahasandana C; Suvatte V; Püng-amritt P; Tuchinda S
    Southeast Asian J Trop Med Public Health; 1979 Jun; 10(2):243-7. PubMed ID: 316576
    [No Abstract]   [Full Text] [Related]  

  • 16. [Factor VIII-related antigen (F VIII R : Ag). Purification by immuno-affinity chromatography].
    Mazurier C; Parquet-Gernez A; Samor B; Goudemand M; Montreuil J
    C R Seances Acad Sci D; 1979 May; 288(18):1431-4. PubMed ID: 115608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two distinct forms of Factor VIII coagulant protein in human plasma. Cleavage by thrombin, and differences in coagulant activity and association with von Willebrand factor.
    Weinstein MJ; Chute LE
    J Clin Invest; 1984 Feb; 73(2):307-16. PubMed ID: 6421875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a F.VIII epitope recognized by a human hemophilic inhibitor.
    Lubahn BC; Ware J; Stafford DW; Reisner HM
    Blood; 1989 Feb; 73(2):497-9. PubMed ID: 2465036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of factor VIII-coagulation antigen in factor VIII concentrates using an inhibitor test].
    Im T; Hintz G
    Arzneimittelforschung; 1986; 36(1):124-6. PubMed ID: 3082340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the stability of factor VIII coagulant antigen (VIII:CAg) in the presence of VIII:C antibodies.
    Furlong RA; Peake IR
    Br J Haematol; 1983 Jan; 53(1):55-63. PubMed ID: 6401211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.